SEARCH THE AGT WEBSITE

Try these: HIVPKULiver CancerImmuno-oncologyGene TherapyBiotech Investment

Subscribe to Our Newsletter

Subscribe to our newsletter to keep up to date with all the latest news about American Gene Technologies!

Follow AGT on Social Media

AGT on Facebook

Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast!www.addimmune.com/jeff-galvin-explains-agts-innovative-approach-to-hiv-on-bio-blast/#genetherapy #biotech #Innovation ... See MoreSee Less
View on Facebook
Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less
View on Facebook
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less
View on Facebook
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less
View on Facebook